Published Date : 2025-Feb-28
Global drug discovery informatics market is projected to witness significant growth by 2025, driven by the rising adoption of AI and cloud computing in drug discovery. This market includes companies specializing in computational drug discovery, data analytics, and bioinformatics solutions. Below, we highlight the top companies leading this industry, along with their overview, website, headquarters, founding year, employees, and revenue (2024 estimates).
The top companies leading this industry: Schrödinger, Certara, PerkinElmer, Merative, Charles River Laboratories, Evotec, Chemaxon, OpenEye and Genedata.
Drug Discovery Informatics Market Size, Share & Trends Analysis Report By function (Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, Other functions), By application (Drug Discovery, Drug Development), By solutions (Software, Services), By end users (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Other End Users), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2025 - 2033
The Drug Discovery Informatics market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Drug Discovery Informatics market.
Market Presence: Operates in over 60 countries, serving major pharmaceutical and biotech companies
Overview: Certara is a leading biosimulation and regulatory science company specializing in drug discovery, development, and regulatory approval processes. By integrating AI, machine learning, and computational modeling, Certara helps pharmaceutical companies accelerate drug development and improve decision-making. Their software and services are widely used across the biopharmaceutical industry, impacting nearly 90% of FDA-approved drugs in the past decade.
With its innovative biosimulation technology, Certara is at the forefront of digital transformation in drug discovery, making it one of the top players in the global drug discovery informatics market in 2025.
Market Presence: Global operations across biotech, pharma, and clinical diagnostics sectors
Overview: PerkinElmer, recently rebranded as Revvity, is a global leader in drug discovery informatics, life sciences, diagnostics, and analytical solutions. The company provides cutting-edge AI-driven data analysis, laboratory automation, and bioinformatics solutions to accelerate pharmaceutical research and development. Their informatics platforms enable faster, more accurate drug discovery, biomarker identification, and clinical research.
With its cutting-edge informatics tools and automation technology, PerkinElmer (Revvity) is one of the top companies shaping the future of drug discovery informatics in 2025.
Market Presence: Global operations across pharma, life sciences, and healthcare sectors
Overview: Merative is a global healthcare analytics and drug discovery informatics company that was formerly known as IBM Watson Health. After being acquired by Francisco Partners in 2022, Merative has continued to develop AI-powered solutions for pharmaceutical research, clinical trials, and healthcare informatics. The company leverages big data, machine learning, and cloud-based analytics to improve decision-making in drug discovery, regulatory processes, and patient care.
With its AI-driven informatics solutions, Merative is playing a key role in transforming drug discovery, clinical research, and healthcare analytics, making it a top leader in the global drug discovery informatics market in 2025.
Market Presence: Global, with over 100 facilities across North America, Europe, and Asia
Overview: Charles River Laboratories (CRL) is a leading contract research organization (CRO) specializing in preclinical drug discovery, safety assessment, and biologics development. The company provides AI-powered informatics solutions, in vivo and in vitro testing, and computational biology to accelerate pharmaceutical R&D. CRL collaborates with biotech, pharmaceutical, and academic institutions to support drug discovery from early-stage research to regulatory approval.
With its comprehensive drug discovery informatics and preclinical testing services, Charles River Laboratories is a key player in the global drug discovery informatics market in 2025, helping bring innovative therapies to market faster.
Market Presence: Global, with research sites in Europe, North America, and Asia
Overview: Evotec is a Germany-based biotechnology company specializing in AI-driven drug discovery, biologics development, and precision medicine. The company partners with pharmaceutical giants, biotech firms, and academic institutions to accelerate small molecule, biologics, and cell therapy research. Evotec’s data-driven platforms integrate AI, machine learning, and high-throughput screening to optimize the drug discovery pipeline from target identification to clinical trials.
With its cutting-edge AI-powered drug discovery platforms, Evotec SE is driving the future of precision medicine and biologics development, making it a top leader in the global drug discovery informatics market in 2025.
Market Presence: Global, serving top pharma and biotech companies
Overview: Chemaxon is a Hungary-based cheminformatics and bioinformatics company specializing in molecular modeling, data management, and computational drug discovery software. The company provides AI-powered solutions for pharmaceutical R&D, chemical informatics, and structure-based drug design. ChemAxon’s tools are widely used by pharmaceutical companies, biotech firms, and academic researchers to accelerate compound screening, molecular visualization, and chemical data analysis.
With its cutting-edge cheminformatics solutions, Chemaxon is driving innovation in molecular modeling and drug discovery informatics, making it one of the top leaders in the global drug discovery informatics market in 2025.
Market Presence: Global, serving top pharmaceutical and biotech firms
Overview: OpenEye, Cadence Molecular Sciences is a leading provider of molecular modeling and computational chemistry software for drug discovery. Acquired by Cadence Design Systems in 2022, OpenEye specializes in cloud-native, physics-based simulations that accelerate small-molecule drug discovery. Their platform integrates quantum mechanics, AI-driven modeling, and GPU-accelerated computing to optimize compound screening and lead identification for pharmaceutical and biotech companies.
With its cutting-edge AI-powered cloud solutions, OpenEye, Cadence Molecular Sciences is revolutionizing drug discovery informatics and computational chemistry, making it a top player in the global drug discovery informatics market in 2025.
Market Presence: Global, serving top pharmaceutical and biotech companies
Overview: Genedata is a bioinformatics and computational biology company specializing in AI-driven drug discovery and biologics R&D automation. Their software solutions help pharmaceutical, biotech, and life sciences companies optimize drug discovery workflows, from early-stage research to clinical development. Genedata's cloud-based data analysis platforms are widely used in genomics, proteomics, and biologics research.
With its cutting-edge AI-powered drug discovery platforms, Genedata is at the forefront of bioinformatics innovation, making it one of the top leaders in the global drug discovery informatics market in 2025.
Market Presence: Globally, with offices in the US, Europe, and Asia
Overview: Schrödinger is a leading computational chemistry and molecular simulation company specializing in drug discovery and materials science. Their cutting-edge physics-based software platform integrates AI, quantum mechanics, and molecular modeling to accelerate drug development. The company collaborates with pharmaceutical and biotech firms to streamline the drug discovery pipeline, reducing time and costs.
With its revolutionary AI-driven simulation technology, Schrödinger is reshaping the pharmaceutical industry and leading the global drug discovery informatics market in 2025.
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
